Simulations Plus
SLP
Performance
About Simulations Plus
Simulations Plus is a biopharma modeling and simulation company offering biosimulation software and consulting services that support drug discovery, development, regulatory submissions, and medical communications. Their software portfolio covers physiologically based pharmacokinetic modeling, quantitative systems pharmacology, pharmacometrics, and related analytics to bridge AI/machine learning with pharmacology. They operate globally, serving clients in pharmaceutical and biotech industries to improve health outcomes through innovative modeling and simulation solutions.
Recent News
Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development
Simulations Plus Posts 8% Q2 Revenue Rise, Raises FY2026 Outlook Amid AI Partnerships
Trump Tax Law Boosts Refunds by $350, Yet 60% of Savings Flow to Top Fifth of Earners
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Recent Deals
No recent deals for this company.